
	Capital Stock and Additional Paid-in Capital
	Stock Outstanding (000s)	Amount
Common shares outstanding as at February 28, 2026	587,431	$	2,924.4
Exercise of stock options	—	—
Common shares issued for restricted share unit settlements	817	—
Stock-based compensation	—	6.5






Common shares issued for employee share purchase plan	400	1.3
Share repurchase	(2,587)	(12.9)
Common shares outstanding as at May 31, 2026	586,061	2,919.3

The Company had 586 million voting common shares outstanding, 20.0 million restricted share units (“RSUs”) and 1.8 million deferred shared units (“DSUs”) outstanding as at June 22, 2026. In addition, 51.5 million common shares are issuable upon conversion in full of the Notes as described in Note 5.

On May 8, 2025, the Company received acceptance from the Toronto Stock Exchange (“TSX”) with respect to a normal course issuer bid (“2025 NCIB”) share buyback program to purchase for cancellation up to 27.9 million common shares of the Company, or approximately 4.7% of the outstanding public float as of May 5, 2025. The 2025 NCIB share buyback program commenced on May 12, 2025, and expired on May 11, 2026.

On May 8, 2026, the Company received acceptance from the TSX for the renewal of its normal course issuer bid (“2026 NCIB”) share buyback program. The 2026 NCIB share buyback program allows for the repurchase of up to 26.8 million of the Company’s common shares, representing approximately 4.58% of the outstanding public float as of April 30, 2026. The 2026 NCIB share buyback program commenced on May 12, 2026, and will expire on May 11, 2027, such date as the Company may determine, or the date on which the maximum number of common shares that may be purchased under the 2026 NCIB share buyback program has been reached. The Company is not obligated to repurchase any common shares under the 2026 NCIB share buyback program.

During the three months ended May 31, 2026, the Company repurchased 2.6 million common shares, at a cost of $10.0 million. All shares were repurchased under the 2025 NCIB share buyback program. The Company recorded a reduction of $12.9 million to capital stock and the amount paid below the per share paid-in capital of the common shares of $2.9 million was recorded to deficit. All common shares repurchased by the Company pursuant to the 2025 NCIB share buyback program have been canceled.